Asian Phytoceuticals PCL (BKK:APCO)

Asian Phytoceuticals PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	231.42	102.51	62.37	125.63	82.15	98.59
Short-Term Investments	106.27	38.36	76.37	102.01	61.25	32.23
Trading Asset Securities	-	218.82	212.92	23.54	35.75	36.09
Cash & Short-Term Investments	337.69	359.69	351.66	251.19	179.15	166.92
Cash Growth	9.51%	2.28%	40.00%	40.21%	7.33%	-2.98%
Accounts Receivable	2.67	2.58	3.38	0.89	0.98	0.54
Other Receivables	1.14	1.18	2.11	3.34	3.23	2.74
Receivables	3.8	3.77	5.49	4.22	4.21	3.29
Inventory	74.13	69.07	57.03	44.27	52.88	59.94
Prepaid Expenses	1.21	0.9	1.14	0.9	0.92	0.67
Other Current Assets	0.19	4.55	0.2	0.23	0.35	0.3
Total Current Assets	417.02	437.97	415.53	300.82	237.51	231.11
Property, Plant & Equipment	38.89	47.97	66.44	82.34	64.02	91.21
Long-Term Investments	121.5	123.84	136.11	303.86	365.01	346.73
Other Intangible Assets	0.59	0.64	0.61	0.79	0.24	0.36
Long-Term Deferred Tax Assets	10.46	11.16	11.18	10.75	7.11	5.05
Other Long-Term Assets	6.19	6.16	6.14	6.17	6.25	6.07
Total Assets	594.65	627.74	636.02	704.72	680.15	680.53

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.37	1.01	0.77	1.2	0.64	1.99
Accrued Expenses	14.52	14.93	16.08	16.47	14.46	14.07
Current Portion of Leases	5.42	11.87	13.2	13.45	12.2	18.74
Current Income Taxes Payable	6.48	8.14	5.2	10.77	12.7	9.64
Current Unearned Revenue	0.39	0.36	0.29	0.26	0.31	0.32
Other Current Liabilities	3.39	4.04	3.12	4.05	4.78	2.99
Total Current Liabilities	30.57	40.36	38.64	46.2	45.1	47.75
Long-Term Leases	0.73	1.79	10.91	22.22	1.62	15.49
Pension & Post-Retirement Benefits	22.17	21.36	22.71	19.88	18.89	17.29
Other Long-Term Liabilities	4.04	4.04	4.04	4.04	4.04	5.01
Total Liabilities	57.5	67.54	76.3	92.34	69.64	85.54

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	300	300	300	300	300	300
Additional Paid-In Capital	166.94	166.94	166.94	166.94	166.94	166.94
Retained Earnings	83	109.31	109.06	161.63	146.3	126.75
Comprehensive Income & Other	-16.84	-19.29	-19.18	-18.88	-5.27	1.3
Total Common Equity	533.1	556.96	556.82	609.7	607.98	594.99
Minority Interest	4.04	3.23	2.89	2.69	2.53	-
Shareholders' Equity	537.15	560.19	559.72	612.39	610.51	594.99
Total Liabilities & Equity	594.65	627.74	636.02	704.72	680.15	680.53

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6.15	13.66	24.11	35.67	13.82	34.23
Net Cash (Debt)	331.54	346.03	327.56	215.52	165.33	132.69
Net Cash Growth	15.35%	5.64%	51.99%	30.36%	24.60%	8.74%
Net Cash Per Share	0.58	0.56	0.54	0.36	0.28	0.22
Filing Date Shares Outstanding	600	600	600	600	600	600
Total Common Shares Outstanding	600	600	600	600	600	600
Working Capital	386.45	397.61	376.88	254.62	192.42	183.36
Book Value Per Share	0.89	0.93	0.93	1.02	1.01	0.99
Tangible Book Value	532.51	556.32	556.22	608.91	607.74	594.64
Tangible Book Value Per Share	0.89	0.93	0.93	1.01	1.01	0.99
Land	-	7.67	8.29	8.29	8.29	8.29
Buildings	-	78.05	90.24	93.72	91.07	91.04
Machinery	-	82.61	82.06	82.71	82.49	82.74

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error